A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule

Inclusion Criteria: * Minimum 20- year-old patients diagnosed with osteoarthritis * Within 2 weeks prior to participation, not taken anti-inflammatory analgesic drug such as the Shinbaro Capsule, Celecoxib Capsule and NSAIDs(non-steroidal anti-inflammatory drugs) * Written consent form voluntarity Exclusion Criteria: * Diagnosed with disease that may affect measurement of efficacy clinically * Diagnosed with clinically significant phycological disorder, and taking medication * Participated in a clinical trial within 4 weeks * Pregnant or lactating woman * History of malignant disease within the previous 5 years * Patients who seem not to participate in the study at investigator's discretion